-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Corvus Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2015 to Q1 2025.
- Corvus Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $22K, a 4.35% decline year-over-year.
- Corvus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2024 was $85K, a 43.7% decline from 2023.
- Corvus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $151K, a 58.9% decline from 2022.
- Corvus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $367K, a 20.2% decline from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)